Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Tumors”

491 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 491 results

Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Not applicableStudy completedNCT03838549
What this trial is testing

Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication

Who this might be right for
Genetic PredispositionBreast Cancer
University Hospital, Montpellier 20
Post-approval studies (Phase 4)Active Not RecruitingNCT05144243
What this trial is testing

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 44
Post-approval studies (Phase 4)Not Yet RecruitingNCT07191379
What this trial is testing

Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Odense University Hospital 50
Early research (Phase 1)Study completedNCT01292603
What this trial is testing

Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 240
Testing effectiveness (Phase 2)Study completedNCT01392079
What this trial is testing

Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine

Who this might be right for
Chronic Lymphocytic Leukemia
University of Ulm 135
Early research (Phase 1)Study completedNCT02738970
What this trial is testing

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 88
Not applicableStudy completedNCT01127867
What this trial is testing

A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women

Who this might be right for
Breast CancerObesity
Rockefeller University 17
Testing effectiveness (Phase 2)Ended earlyNCT01465386
What this trial is testing

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more
Fred Hutchinson Cancer Center 6
Early research (Phase 1)Ended earlyNCT04895410
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 8
Testing effectiveness (Phase 2)Study completedNCT03054909
What this trial is testing

IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer

Who this might be right for
FIGO Stage III and IV Ovarian CancerFIGO Stage III and IV Fallopian Tube CancerFIGO Stage III Primary Peritoneal Cancer
Masonic Cancer Center, University of Minnesota 7
Not applicableUnknownNCT04461847
What this trial is testing

ESM Versus OM ：A Randomized Controlled Trial

Who this might be right for
Endoscopic Subcutaneous Mastectomy
Beijing Friendship Hospital 287
Large-scale testing (Phase 3)Study completedNCT01461928
What this trial is testing

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 692
Not applicableStudy completedNCT02611739
What this trial is testing

Medi-Port Pilot Randomized Controlled Trial

Who this might be right for
Actively Undergoing Cancer Treatment4-9 Years of AgeAt Least 1 Month From Diagnosis+2 more
The Hospital for Sick Children 40
Early research (Phase 1)Study completedNCT01628640
What this trial is testing

Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmHepatocellular Carcinoma
Mayo Clinic 17
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Large-scale testing (Phase 3)Study completedNCT05804032
What this trial is testing

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 514
Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46
Early research (Phase 1)Ended earlyNCT02508441
What this trial is testing

Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors

Who this might be right for
Advanced Unresectable Solid Tumors
Andes Biotechnologies 22
Large-scale testing (Phase 3)Study completedNCT03730129
What this trial is testing

Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

Who this might be right for
Secondary Immune Deficiency Disorder
Rochester General Hospital 20
Load More Results